CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 78.1% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English

Trade Arcadia Biosciences, Inc. - RKDA CFD

2.23
1.36%
  • Summary
  • Historical Data
  • Events
Trading сonditions
Spread 0.08
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.026179 %
Charges from full value of position ($-4.97)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026179%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.003957 %
Charges from full value of position ($0.75)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.003957%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Key Stats
Prev. Close* 2.21
Open* 2.19
1-Year Change* -70.95%
Day's Range* 2.16 - 2.25
52 wk Range N/A
Average Volume (10 days) N/A
Average Volume (3 months) N/A
Market Cap N/A
P/E Ratio N/A
Shares Outstanding N/A
Revenue N/A
EPS N/A
Dividend (Yield %) N/A
Beta N/A
Next Earnings Date N/A

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Mar 28, 2024 2.24 0.00 0.00% 2.24 2.25 2.16
Mar 27, 2024 2.21 -0.03 -1.34% 2.24 2.29 2.18
Mar 26, 2024 2.27 0.08 3.65% 2.19 2.30 2.19
Mar 25, 2024 2.25 0.07 3.21% 2.18 2.26 2.18
Mar 22, 2024 2.23 0.05 2.29% 2.18 2.23 2.18
Mar 21, 2024 2.19 -0.16 -6.81% 2.35 2.56 2.15
Mar 20, 2024 2.33 0.00 0.00% 2.33 2.35 2.33
Mar 19, 2024 2.36 -0.02 -0.84% 2.38 2.40 2.33
Mar 18, 2024 2.41 -0.03 -1.23% 2.44 2.46 2.36
Mar 15, 2024 2.51 0.02 0.80% 2.49 2.51 2.49
Mar 14, 2024 2.47 0.02 0.82% 2.45 2.47 2.43
Mar 13, 2024 2.49 0.04 1.63% 2.45 2.50 2.43
Mar 12, 2024 2.47 -0.08 -3.14% 2.55 2.55 2.45
Mar 11, 2024 2.45 -0.07 -2.78% 2.52 2.52 2.42
Mar 8, 2024 2.48 0.02 0.81% 2.46 2.48 2.44
Mar 7, 2024 2.45 0.04 1.66% 2.41 2.46 2.40
Mar 6, 2024 2.49 -0.09 -3.49% 2.58 2.59 2.42
Mar 5, 2024 2.56 -0.05 -1.92% 2.61 2.62 2.48
Mar 4, 2024 2.64 -0.02 -0.75% 2.66 2.71 2.63
Mar 1, 2024 2.71 -0.05 -1.81% 2.76 2.76 2.71

Arcadia Biosciences, Inc. Events

Time (UTC) Country Event
No events scheduled
View all events

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Arcadia Biosciences, Inc. Company profile

About Arcadia Biosciences Inc

Arcadia Biosciences, Inc is engaged in developing crop improvements. The Company develops crops in wheat, soy and hemp, designed for farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health and wellness products for industrial applications. It uses breeding techniques to develop. The Company's GoodWheat product ingredients deliver health benefits to consumers and enable consumer packaged goods companies to differentiate their brands in the marketplace. Its GoodHemp seed catalog delivers hemp seeds, transplants and extracts. It offers Sonova GLA Safflower Oil by growing safflower plants producing seed which are high in gamma-linolenic acid (GLA). It also offers its Sonova GLA as a nutritional additive to adult dry dog and cat food formulations.

Financial summary

BRIEF: For the nine months ended 30 September 2021, Arcadia Biosciences Inc revenues increased from $904K to $4.6M. Net loss decreased 60% to $5.4M. Revenues reflect SubTotal increase from $630K to $4.5M, Royalty increase of 48% to $86K. Lower net loss reflects Other income, net increase from $82K to $10.2M (income), Research and development - Balancing decrease of 63% to $2.1M (expense), Valuation of Inventory - Gain/Loss decrease of 39% to $1.8M (expense).

News

A way forward: a roundup of recent central bank decisions

Five of the world’s most significant central banks delivered policy this week. We review the decisions and discuss their impact on the markets.

12:47, 22 March 2024

Bank of Japan Preview: will the BOJ end negative interest rates?

The Bank of Japan meets on Tuesday 19th of March. We preview what to expect from the BOJ decision and how it might impact the USD/JPY and Nikkei 225.

08:44, 18 March 2024

Higher CPI leaves traders unfazed as US equities continue to build momentum

The latest US CPI reading hasn’t gone how the Federal would have hoped. Consumer prices came in higher than expected in February for the third month in a row.

12:42, 15 March 2024

Four reasons why Bitcoin is surging to record highs

Bitcoin has surged to record highs. We discuss the four factors pushing Bitcoin higher and analyse the technicals of the cryptocurrency’s technicals.

10:18, 14 March 2024

China’s National People’s Congress: The markets have again been left wanting more

China’s National People’s Congress (NPC) is underway, and the markets have so far been disappointed by what’s been delivered by the country’s central government. We look at some of the significant takeaways from the event, discuss China’s current economic conditions, and analyse the China A50.

08:23, 8 March 2024
Facade on the Federal Reserve Building in Washington DC

Central Banks: which one will cut first?

Central banks dominate the calendar in March and markets try to anticipate which one will be the first one to cut

13:14, 6 March 2024

Nvidia (NVDA) confronts high expectations for Q4 results

Nvidia is arguably the hottest company on the planet. The company reports its Q4 results after the closing bell on Wednesday, the 21st of February. We preview what to expect from Nvidia’s earnings and analyse the technicals of its stock price.

12:13, 20 February 2024

People also watch

Gold

2,233.43 Price
+1.740% 1D Chg, %
Long position overnight fee -0.0188%
Short position overnight fee 0.0106%
Overnight fee time 21:00 (UTC)
Spread 0.80

XRP/USD

0.62 Price
-1.590% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01168

US100

18,249.40 Price
-0.200% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 21:00 (UTC)
Spread 7.0

BTC/USD

70,126.15 Price
-0.570% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 106.00

Still looking for a broker you can trust?

Join the 580.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading